{"context":{"query":">>efo>>gwas","source_dataset":"efo","target_dataset":"gwas"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]EFO:0001075,72,EFO:0001075,38,1]["},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"EFO:0001075","source":"EFO:0001075|ovarian carcinoma","targets":["GCST000455_1|Ovarian cancer|BNC2 - RN7SL720P|9|5.000000e-19","GCST000800_1|Ovarian cancer|BABAM1, USHBP1|19|4.000000e-06","GCST000800_2|Ovarian cancer|ANKLE1|19|1.000000e-07","GCST000802_1|Ovarian cancer|TIPARP, TIPARP-AS1|3|3.000000e-07","GCST000802_2|Ovarian cancer|WNT4 - MIR4418|1|5.000000e-06","GCST000802_3|Ovarian cancer|LUZP2 - RPL36AP40|11|5.000000e-06","GCST000802_4|Ovarian cancer|HAGLR, HAGLROS|2|5.000000e-14","GCST000802_5|Ovarian cancer|LINC00824|8|3.000000e-09","GCST000802_6|Ovarian cancer|SKAP1|17|1.000000e-06","GCST000802_7|Ovarian cancer|SKAP1|17|2.000000e-06","GCST001258_1|Ovarian cancer|BRIP1|17|6.000000e-13","GCST001917_1|Ovarian cancer in BRCA1 mutation carriers|PLEKHM1|17|1.000000e-08","GCST001917_2|Ovarian cancer in BRCA1 mutation carriers|NSF|17|3.000000e-08","GCST001917_3|Ovarian cancer in BRCA1 mutation carriers|BNC2 - RN7SL720P|9|6.000000e-11","GCST001917_4|Ovarian cancer in BRCA1 mutation carriers|TIPARP, TIPARP-AS1|3|7.000000e-06","GCST001917_5|Ovarian cancer in BRCA1 mutation carriers|PLEKHM1|17|1.000000e-08","GCST001917_6|Ovarian cancer in BRCA1 mutation carriers|NSF|17|3.000000e-08","GCST001917_7|Ovarian cancer in BRCA1 mutation carriers|TRIM61 - RPL21P51|4|3.000000e-08","GCST001941_1|Ovarian cancer|BNC2 - RN7SL720P|9|4.000000e-29","GCST001941_10|Ovarian cancer|BABAM1, USHBP1|19|3.000000e-14","GCST001941_11|Ovarian cancer|SKAP1|17|6.000000e-09","GCST001941_12|Ovarian cancer|SKAP1|17|3.000000e-10","GCST001941_13|Ovarian cancer|CHMP4C|8|6.000000e-09","GCST001941_14|Ovarian cancer|MLLT10|10|2.000000e-08","GCST001941_15|Ovarian cancer|MLLT10|10|1.000000e-07","GCST001941_16|Ovarian cancer|HNF1B|17|8.000000e-10","GCST001941_17|Ovarian cancer|CHMP4C|8|7.000000e-10","GCST001941_2|Ovarian cancer|BNC2 - RN7SL720P|9|4.000000e-32","GCST001941_3|Ovarian cancer|LINC00824|8|3.000000e-12","GCST001941_4|Ovarian cancer|LINC00824|8|1.000000e-17","GCST001941_5|Ovarian cancer|HAGLR, HAGLROS|2|5.000000e-11","GCST001941_6|Ovarian cancer|HAGLR, HAGLROS|2|3.000000e-10","GCST001941_7|Ovarian cancer|TIPARP, TIPARP-AS1|3|2.000000e-29","GCST001941_8|Ovarian cancer|TIPARP, TIPARP-AS1|3|2.000000e-34","GCST001941_9|Ovarian cancer|BABAM1, USHBP1|19|2.000000e-07","GCST003587_1|Cancer|GBA1LP, GBA1LP|1|2.000000e-07","GCST003587_10|Cancer|CDKN2B-AS1|9|2.000000e-07","GCST003587_11|Cancer|SH2B3, ATXN2|12|2.000000e-06","GCST003587_12|Cancer|BRCA2|13|8.000000e-12","GCST003587_13|Cancer|HNF1B|17|1.000000e-09","GCST003587_14|Cancer|BABAM1, USHBP1|19|4.000000e-07","GCST003587_15|Cancer|RPS2P1 - ASIP|20|3.000000e-09","GCST003587_16|Cancer|FRY|13|1.000000e-07","GCST003587_17|Cancer|RALY|20|2.000000e-08","GCST003587_2|Cancer|GBA1LP, GBA1LP, MTX1|1|2.000000e-07","GCST003587_3|Cancer|KCNH1|1|1.000000e-07","GCST003587_4|Cancer|LINC01997 - MECOM|3|2.000000e-07","GCST003587_5|Cancer|UBQLN1P1 - MICC|6|2.000000e-06","GCST003587_6|Cancer|LINC02571 - HLA-B|6|9.000000e-06","GCST003587_7|Cancer|HLA-DQB1 - MTCO3P1|6|5.000000e-07","GCST003587_8|Cancer|RPL17P25 - RPSAP72|6|6.000000e-06","GCST003587_9|Cancer|MTAP - CDKN2A-AS1|9|6.000000e-06","GCST003588_1|Cancer (pleiotropy)|DVL1 - MXRA8|1|5.000000e-10","GCST003588_10|Cancer (pleiotropy)|HLA-DQB1 - MTCO3P1|6|6.000000e-08","GCST003588_11|Cancer (pleiotropy)|CDKN2B-AS1|9|5.000000e-06","GCST003588_12|Cancer (pleiotropy)|FGFR2|10|8.000000e-35","GCST003588_13|Cancer (pleiotropy)|SMIM38 - MYEOV|11|4.000000e-14","GCST003588_14|Cancer (pleiotropy)|PDGFDDN|11|3.000000e-08","GCST003588_15|Cancer (pleiotropy)|TUBA1C|12|9.000000e-07","GCST003588_16|Cancer (pleiotropy)|KRT8|12|2.000000e-15","GCST003588_17|Cancer (pleiotropy)|SH2B3, ATXN2|12|1.000000e-06","GCST003588_18|Cancer (pleiotropy)|BRCA2|13|5.000000e-10","GCST003588_19|Cancer (pleiotropy)|FRY|13|4.000000e-09","GCST003588_2|Cancer (pleiotropy)|GBA1LP, GBA1LP, MTX1|1|5.000000e-06","GCST003588_20|Cancer (pleiotropy)|RAD51B|14|3.000000e-10","GCST003588_21|Cancer (pleiotropy)|HNF1B|17|7.000000e-28","GCST003588_22|Cancer (pleiotropy)|BABAM1, USHBP1|19|2.000000e-09","GCST003588_23|Cancer (pleiotropy)|RPS2P1 - ASIP|20|3.000000e-06","GCST003588_24|Cancer (pleiotropy)|PDGFDDN|11|1.000000e-07","GCST003588_25|Cancer (pleiotropy)|ATXN2-AS|12|5.000000e-06","GCST003588_26|Cancer (pleiotropy)|RALY|20|6.000000e-06","GCST003588_3|Cancer (pleiotropy)|NEK10|3|2.000000e-09","GCST003588_4|Cancer (pleiotropy)|RNU6-351P - TET2|4|1.000000e-10","GCST003588_5|Cancer (pleiotropy)|TERT|5|2.000000e-10","GCST003588_6|Cancer (pleiotropy)|C5orf67 - MAP3K1|5|4.000000e-12","GCST003588_7|Cancer (pleiotropy)|HLA-F-AS1|6|1.000000e-06","GCST003588_8|Cancer (pleiotropy)|UBQLN1P1 - MICC|6|5.000000e-07","GCST003588_9|Cancer (pleiotropy)|LINC02571 - HLA-B|6|3.000000e-07","GCST004414_1|Ovarian cancer in BRCA1 mutation carriers|TIPARP-AS1|3|5.000000e-07","GCST004414_2|Ovarian cancer in BRCA1 mutation carriers|TRIM61 - RPL21P51|4|4.000000e-07","GCST004414_3|Ovarian cancer in BRCA1 mutation carriers|BNC2 - RN7SL720P|9|1.000000e-14","GCST004414_4|Ovarian cancer in BRCA1 mutation carriers|PLEKHM1|17|7.000000e-06","GCST004415_1|Invasive epithelial ovarian cancer|HOXD3, HAGLR|2|4.000000e-14","GCST004415_10|Invasive epithelial ovarian cancer|||8.000000e-10","GCST004415_11|Invasive epithelial ovarian cancer|MLLT10|10|8.000000e-10","GCST004415_12|Invasive epithelial ovarian cancer|RCCD1|15|5.000000e-07","GCST004415_13|Invasive epithelial ovarian cancer|ATAD5|17|1.000000e-07","GCST004415_14|Invasive epithelial ovarian cancer|PLEKHM1|17|2.000000e-13","GCST004415_15|Invasive epithelial ovarian cancer|SKAP1|17|8.000000e-13","GCST004415_16|Invasive epithelial ovarian cancer|BABAM1, USHBP1|19|2.000000e-17","GCST004415_17|Invasive epithelial ovarian cancer|TTC28|22|3.000000e-07","GCST004415_18|Invasive epithelial ovarian cancer|MIR4435-2HG, ACOXL|2|8.000000e-07","GCST004415_19|Invasive epithelial ovarian cancer|HNF1A-AS1|12|6.000000e-06","GCST004415_2|Invasive epithelial ovarian cancer|HAGLROS, HAGLR|2|4.000000e-14","GCST004415_3|Invasive epithelial ovarian cancer|TIPARP-AS1|3|5.000000e-38","GCST004415_4|Invasive epithelial ovarian cancer|SYNPO2|4|3.000000e-06","GCST004415_5|Invasive epithelial ovarian cancer|TERT|5|3.000000e-08","GCST004415_6|Invasive epithelial ovarian cancer|TERT|5|7.000000e-10","GCST004415_7|Invasive epithelial ovarian cancer|||2.000000e-08","GCST004415_8|Invasive epithelial ovarian cancer|LINC00824|8|7.000000e-16"]}]}